Eculizumab treatment for myasthenia gravis subgroups: 2021 update
Jiao Li, Honghao Li, Shougang Guo
Topics & Concepts
EculizumabMedicineMyasthenia gravisRefractory (planetary science)TolerabilityInternal medicineComplement systemPlaceboClinical trialGastroenterologyPhases of clinical researchMonoclonalAntibodyImmunologyAdverse effectMonoclonal antibodyPathologyBiologyAstrobiologyAlternative medicineMyasthenia Gravis and ThymomaAntifungal resistance and susceptibilityPeripheral Neuropathies and Disorders